Please login to the form below

Not currently logged in
Email:
Password:

Achilles

This page shows the latest Achilles news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Neoantigen player Achilles gets OK for first clinical trial Neoantigen player Achilles gets OK for first clinical trial

    Will test the candidate in advanced NSCLC patients. Achilles Therapeutics is now a clinical-stage biotech after getting regulatory approval to start a phase 1/2 trial of its lead lung ... Approval of our first [clinical trial application] represents an

  • Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3 Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

    Phase 1 data have revealed activity in HER2-positive breast, lung and gastric cancers, without dose-limiting toxicities that have been the Achilles’ heel of many ADC therapies to date.

  • Outside looking in Outside looking in

    We know that as an industry this has long been our Achilles heel as other, easier to measure elements of the sales and marketing mix steal the lion’s share of

  • Antibiotics: pharma's Cinderella story Antibiotics: pharma's Cinderella story

    Yet perhaps the industry's greatest triumph has an Achilles heel. The dawn of the commercial age.

  • Cleaning up pharma's supply chain Cleaning up pharma's supply chain

    And that presents a problem in itself. As highlighted by recent reports from KPMG, IBM and Achilles, across the globe major corporations demonstrate a worrying lack of knowledge about their supply ... director of pharmaceutical and healthcare at Achilles

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...

Infographics